Regulatory Hurdles for Increased Availability of Cannabis-Infused Edibles

Video

 

Merril Gilbert, founder and CEO of TraceTrust: One is getting it declassified as a Schedule I narcotic. It’s clearly not that. There is no addictive qualities: it’s a combination of other things. But it’s also, again, how do I counteract it and not knowing how it’s going to react for different people. You’re going to have the same reaction as if you have a peanut allergy and we have to be really conscious of that. So, again, creating a standard like we’re doing in this same manner and together with other types of certifications –nonGMO and vegan– and really aligning together, raising up together and not competing against each other is crucial now.

Related Videos
technology
© 2024 MJH Life Sciences

All rights reserved.